[ad_1]
New York, December 13, 2021 /PRNewswire/ – Levi & Korsinsky, LLP issued the following statement:
To: All individuals or entities that purchase or otherwise obtain Revance Therapeutics, Inc. securities. (“Revance” or “Company”) (NASDAQ:RVNC) between November 25, 2019 and October 11, 2021. Hereby inform you The securities class action has been America North District District Court California. For more information, please visit:
https://www.zlk.com/pslra-1/revance-therapeutics-inc-information-request-form
Or contact Joseph E. Levi, Esq. through email
The full story can be found on Benzinga.com
[ad_2]
Source link
